Anti-B-cell maturation antigen (BCMA) antibodies are used to treat multiple myeloma, a type of blood cancer. These medications work by targeting the BCMA protein on the surface of cancer cells, helping your immune system to recognize and destroy these cells. Anti-BCMA antibodies are available as injections. One example is Tecvayli (teclistamab). These treatments offer a targeted approach to managing your condition.
